+Follow
WenxinLee
No personal profile
5
Follow
0
Followers
0
Topic
0
Badge
Posts
Hot
WenxinLee
2021-09-21
Nice
BioNTech SE stock jumped 4% in morning trading
WenxinLee
2021-09-07
Nice
U.S. Stock Futures Edge Higher
WenxinLee
2021-09-05
Nice
Sorry, the original content has been removed
WenxinLee
2021-09-03
Nice
Bitcoin may be clearing resistance at 3-month high; Ether rallies to $4K
WenxinLee
2021-09-02
Nice
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4087695368272510","uuid":"4087695368272510","gmtCreate":1624592307491,"gmtModify":1629171049099,"name":"WenxinLee","pinyin":"wenxinlee","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":5,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":860767592,"gmtCreate":1632215849816,"gmtModify":1676530726799,"author":{"id":"4087695368272510","authorId":"4087695368272510","name":"WenxinLee","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087695368272510","authorIdStr":"4087695368272510"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860767592","repostId":"1189685868","repostType":4,"repost":{"id":"1189685868","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631714905,"share":"https://ttm.financial/m/news/1189685868?lang=&edition=fundamental","pubTime":"2021-09-15 22:08","market":"us","language":"en","title":"BioNTech SE stock jumped 4% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1189685868","media":"Tiger Newspress","summary":"BioNTech SE stock jumped 4% in morning trading as Pfizer said booster shots of vaccine restore wanin","content":"<p>BioNTech SE stock jumped 4% in morning trading as Pfizer said booster shots of vaccine restore waning Immunity.Pfizer shares rose 0.7%.</p>\n<p><img src=\"https://static.tigerbbs.com/fb4c307ca1b61c145bfb12a955ecf588\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Pfizer Inc. said that data from the U.S. and Israel suggest that the efficacy of its Covid-19 vaccine wanes over time, and that a booster dose was safe and effective at warding off the virus and new variants.</p>\n<p>The company detailed the data in a presentation it will deliver to a meeting of outside advisers to the Food and Drug Administration on Friday. The panel is expected to make recommendations for whether more Americans should receive booster shots.</p>\n<p>“Real-world data from Israel and the United States suggest that rates of breakthrough infections are rising faster in individuals who were vaccinated earlier,” Pfizer said in its presentation, which was posted on the FDA website. The drug giant is partnering with Germany’s BioNTech SE to make the shots.</p>\n<p>The decrease in effectiveness is “primarily due to waning of vaccine immune responses over time,” rather than the delta variant, Pfizer researchers said in the presentation.</p>\n<p><b>Unpublished Data</b></p>\n<p>According to a meeting agenda the FDA posted on its website, in addition to the Pfizer presentation, the Friday panel will include presentations from the Centers for Disease Control and Prevention, FDA staff and researchers from Israel and the U.K.</p>\n<p>The Israel officials will present data from that country on booster protection against infections and severe disease, according to the agenda, and a professor of medical statistics from the University of Bristol will present data on real-world vaccine effectiveness.</p>\n<p>While its vaccine continues to provide strong protection against hospitalizations and severe disease in the U.S., Pfizer said, data from Israel and elsewhere suggests that reduction in efficacy against infection may be followed by reduced effectiveness against severe disease, especially among vulnerable elderly people.</p>\n<p>Early unpublished data from an Israeli health maintenance organization suggest that a third booster dose is highly effective in areas where the delta variant is dominant, according to the Pfizer document. Giving a third dose to people more than 60 years old was associated with 86% effectiveness against testing positive for Covid starting at least a week after the booster, Pfizer said.</p>\n<p>Pfizer also detailed immune response results from a final-stage trial of booster shots in over 300 people, showing that a third dose bolstered blood antibody levels. One month after the third dose, levels of the protective antibodies were more than triple what they had been a month after the second shot.</p>\n<p>No new unexpected side effects were identified from safety data associated with boosters in the final-stage study, according to the Pfizer report. Consideration of a booster dose six months after a second dose of its shot is warranted, based on similarities between the outbreaks in Israel and the U.S., Pfizer said.</p>\n<p><b>Signs of Friction</b></p>\n<p>Marion Gruber, one of two top vaccine officials who FDA recently said will step down later this year, is also scheduled to speak. Gruber was co-author of an article in The Lancet earlier this week arguing that booster shots weren’t yet necessary for most people. The departures of the two longtime agency staff are a potential sign of friction over the Biden booster plan.</p>\n<p>The FDA hasn’t yet posted its staff report on the booster data. The agency’s documents are typically released 48 hours before the start of a panel meeting.</p>\n<p>The FDA is working as quickly as possible to post the items throughout the day as they are finalized and available, spokesperson Alison Hunt said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech SE stock jumped 4% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech SE stock jumped 4% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-15 22:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech SE stock jumped 4% in morning trading as Pfizer said booster shots of vaccine restore waning Immunity.Pfizer shares rose 0.7%.</p>\n<p><img src=\"https://static.tigerbbs.com/fb4c307ca1b61c145bfb12a955ecf588\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Pfizer Inc. said that data from the U.S. and Israel suggest that the efficacy of its Covid-19 vaccine wanes over time, and that a booster dose was safe and effective at warding off the virus and new variants.</p>\n<p>The company detailed the data in a presentation it will deliver to a meeting of outside advisers to the Food and Drug Administration on Friday. The panel is expected to make recommendations for whether more Americans should receive booster shots.</p>\n<p>“Real-world data from Israel and the United States suggest that rates of breakthrough infections are rising faster in individuals who were vaccinated earlier,” Pfizer said in its presentation, which was posted on the FDA website. The drug giant is partnering with Germany’s BioNTech SE to make the shots.</p>\n<p>The decrease in effectiveness is “primarily due to waning of vaccine immune responses over time,” rather than the delta variant, Pfizer researchers said in the presentation.</p>\n<p><b>Unpublished Data</b></p>\n<p>According to a meeting agenda the FDA posted on its website, in addition to the Pfizer presentation, the Friday panel will include presentations from the Centers for Disease Control and Prevention, FDA staff and researchers from Israel and the U.K.</p>\n<p>The Israel officials will present data from that country on booster protection against infections and severe disease, according to the agenda, and a professor of medical statistics from the University of Bristol will present data on real-world vaccine effectiveness.</p>\n<p>While its vaccine continues to provide strong protection against hospitalizations and severe disease in the U.S., Pfizer said, data from Israel and elsewhere suggests that reduction in efficacy against infection may be followed by reduced effectiveness against severe disease, especially among vulnerable elderly people.</p>\n<p>Early unpublished data from an Israeli health maintenance organization suggest that a third booster dose is highly effective in areas where the delta variant is dominant, according to the Pfizer document. Giving a third dose to people more than 60 years old was associated with 86% effectiveness against testing positive for Covid starting at least a week after the booster, Pfizer said.</p>\n<p>Pfizer also detailed immune response results from a final-stage trial of booster shots in over 300 people, showing that a third dose bolstered blood antibody levels. One month after the third dose, levels of the protective antibodies were more than triple what they had been a month after the second shot.</p>\n<p>No new unexpected side effects were identified from safety data associated with boosters in the final-stage study, according to the Pfizer report. Consideration of a booster dose six months after a second dose of its shot is warranted, based on similarities between the outbreaks in Israel and the U.S., Pfizer said.</p>\n<p><b>Signs of Friction</b></p>\n<p>Marion Gruber, one of two top vaccine officials who FDA recently said will step down later this year, is also scheduled to speak. Gruber was co-author of an article in The Lancet earlier this week arguing that booster shots weren’t yet necessary for most people. The departures of the two longtime agency staff are a potential sign of friction over the Biden booster plan.</p>\n<p>The FDA hasn’t yet posted its staff report on the booster data. The agency’s documents are typically released 48 hours before the start of a panel meeting.</p>\n<p>The FDA is working as quickly as possible to post the items throughout the day as they are finalized and available, spokesperson Alison Hunt said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189685868","content_text":"BioNTech SE stock jumped 4% in morning trading as Pfizer said booster shots of vaccine restore waning Immunity.Pfizer shares rose 0.7%.\n\nPfizer Inc. said that data from the U.S. and Israel suggest that the efficacy of its Covid-19 vaccine wanes over time, and that a booster dose was safe and effective at warding off the virus and new variants.\nThe company detailed the data in a presentation it will deliver to a meeting of outside advisers to the Food and Drug Administration on Friday. The panel is expected to make recommendations for whether more Americans should receive booster shots.\n“Real-world data from Israel and the United States suggest that rates of breakthrough infections are rising faster in individuals who were vaccinated earlier,” Pfizer said in its presentation, which was posted on the FDA website. The drug giant is partnering with Germany’s BioNTech SE to make the shots.\nThe decrease in effectiveness is “primarily due to waning of vaccine immune responses over time,” rather than the delta variant, Pfizer researchers said in the presentation.\nUnpublished Data\nAccording to a meeting agenda the FDA posted on its website, in addition to the Pfizer presentation, the Friday panel will include presentations from the Centers for Disease Control and Prevention, FDA staff and researchers from Israel and the U.K.\nThe Israel officials will present data from that country on booster protection against infections and severe disease, according to the agenda, and a professor of medical statistics from the University of Bristol will present data on real-world vaccine effectiveness.\nWhile its vaccine continues to provide strong protection against hospitalizations and severe disease in the U.S., Pfizer said, data from Israel and elsewhere suggests that reduction in efficacy against infection may be followed by reduced effectiveness against severe disease, especially among vulnerable elderly people.\nEarly unpublished data from an Israeli health maintenance organization suggest that a third booster dose is highly effective in areas where the delta variant is dominant, according to the Pfizer document. Giving a third dose to people more than 60 years old was associated with 86% effectiveness against testing positive for Covid starting at least a week after the booster, Pfizer said.\nPfizer also detailed immune response results from a final-stage trial of booster shots in over 300 people, showing that a third dose bolstered blood antibody levels. One month after the third dose, levels of the protective antibodies were more than triple what they had been a month after the second shot.\nNo new unexpected side effects were identified from safety data associated with boosters in the final-stage study, according to the Pfizer report. Consideration of a booster dose six months after a second dose of its shot is warranted, based on similarities between the outbreaks in Israel and the U.S., Pfizer said.\nSigns of Friction\nMarion Gruber, one of two top vaccine officials who FDA recently said will step down later this year, is also scheduled to speak. Gruber was co-author of an article in The Lancet earlier this week arguing that booster shots weren’t yet necessary for most people. The departures of the two longtime agency staff are a potential sign of friction over the Biden booster plan.\nThe FDA hasn’t yet posted its staff report on the booster data. The agency’s documents are typically released 48 hours before the start of a panel meeting.\nThe FDA is working as quickly as possible to post the items throughout the day as they are finalized and available, spokesperson Alison Hunt said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880071750,"gmtCreate":1631004175570,"gmtModify":1676530439850,"author":{"id":"4087695368272510","authorId":"4087695368272510","name":"WenxinLee","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087695368272510","authorIdStr":"4087695368272510"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/880071750","repostId":"1118393732","repostType":4,"repost":{"id":"1118393732","kind":"news","pubTimestamp":1631000928,"share":"https://ttm.financial/m/news/1118393732?lang=&edition=fundamental","pubTime":"2021-09-07 15:48","market":"us","language":"en","title":"U.S. Stock Futures Edge Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=1118393732","media":"The Wall Street Journal","summary":"Government bond yields gained.\n\nU.S. stock futures inched up early Tuesday, suggesting Wall Street i","content":"<blockquote>\n <b>Government bond yields gained.</b>\n</blockquote>\n<p><img src=\"https://static.tigerbbs.com/1ca748110483255bd1827aee3d1e7158\" tg-width=\"900\" tg-height=\"522\" width=\"100%\" height=\"auto\">U.S. stock futures inched up early Tuesday, suggesting Wall Street indexes would open higher as traders returned from the Labor Day holiday weekend.</p>\n<p>S&P 500 futures gained 0.1% and futures on the Dow Jones Industrial Average also added 0.1%. Changes in equity futures don’t necessarily predict market moves after the markets open.</p>\n<p>In Europe, the Stoxx Europe 600 shed 0.1% in morning trade as gains in communication services and materials sectors were balanced by losses in consumer discretionary and energy sectors.</p>\n<p>DS SmithPLC jumped 2.8% for a two-day winning streak and Marks and Spencer Group added 2.6%.</p>\n<p>The U.K.’s FTSE 100, which is dominated by large international businesses, was lower 0.2%. Other stock in Europe were mixed as France’s CAC 40 edged up 0.1% and Germany’s DAX declined 0.1%.</p>\n<p>The Swiss franc was up 0.1% against the U.S. dollar, with 1 franc buying $1.09. The euro was mostly flat against the dollar, with 1 euro buying $1.19. The British pound slipped 0.1% against the dollar, with 1 pound buying $1.38.</p>\n<p>In commodities, Brent crude rose 0.1% to $72.28 a barrel. Gold fell 0.7% to $1,821.20 a troy ounce.</p>\n<p>German 10-year bund yields were up to minus 0.343% and the yield on U.K. 10-year gilts gained to 0.621%. The yield on 10-year U.S. Treasury rose to 1.353% from 1.322% on Friday. Bond yields and prices move inversely.</p>\n<p>Stocks in Asia mostly climbed as Hong Kong’s Hang Seng rose 1%, Japan’s Nikkei 225 index added 0.9% and China’s benchmark Shanghai Composite gained 1.5%.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stock Futures Edge Higher</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stock Futures Edge Higher\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-07 15:48 GMT+8 <a href=https://www.wsj.com/articles/global-stock-markets-dow-update-09-07-2021-11631000676?mod=markets_lead_pos1><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Government bond yields gained.\n\nU.S. stock futures inched up early Tuesday, suggesting Wall Street indexes would open higher as traders returned from the Labor Day holiday weekend.\nS&P 500 futures ...</p>\n\n<a href=\"https://www.wsj.com/articles/global-stock-markets-dow-update-09-07-2021-11631000676?mod=markets_lead_pos1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.wsj.com/articles/global-stock-markets-dow-update-09-07-2021-11631000676?mod=markets_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118393732","content_text":"Government bond yields gained.\n\nU.S. stock futures inched up early Tuesday, suggesting Wall Street indexes would open higher as traders returned from the Labor Day holiday weekend.\nS&P 500 futures gained 0.1% and futures on the Dow Jones Industrial Average also added 0.1%. Changes in equity futures don’t necessarily predict market moves after the markets open.\nIn Europe, the Stoxx Europe 600 shed 0.1% in morning trade as gains in communication services and materials sectors were balanced by losses in consumer discretionary and energy sectors.\nDS SmithPLC jumped 2.8% for a two-day winning streak and Marks and Spencer Group added 2.6%.\nThe U.K.’s FTSE 100, which is dominated by large international businesses, was lower 0.2%. Other stock in Europe were mixed as France’s CAC 40 edged up 0.1% and Germany’s DAX declined 0.1%.\nThe Swiss franc was up 0.1% against the U.S. dollar, with 1 franc buying $1.09. The euro was mostly flat against the dollar, with 1 euro buying $1.19. The British pound slipped 0.1% against the dollar, with 1 pound buying $1.38.\nIn commodities, Brent crude rose 0.1% to $72.28 a barrel. Gold fell 0.7% to $1,821.20 a troy ounce.\nGerman 10-year bund yields were up to minus 0.343% and the yield on U.K. 10-year gilts gained to 0.621%. The yield on 10-year U.S. Treasury rose to 1.353% from 1.322% on Friday. Bond yields and prices move inversely.\nStocks in Asia mostly climbed as Hong Kong’s Hang Seng rose 1%, Japan’s Nikkei 225 index added 0.9% and China’s benchmark Shanghai Composite gained 1.5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":814554788,"gmtCreate":1630850094244,"gmtModify":1676530405697,"author":{"id":"4087695368272510","authorId":"4087695368272510","name":"WenxinLee","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087695368272510","authorIdStr":"4087695368272510"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/814554788","repostId":"1186003479","repostType":4,"isVote":1,"tweetType":1,"viewCount":241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815268544,"gmtCreate":1630681248188,"gmtModify":1676530375916,"author":{"id":"4087695368272510","authorId":"4087695368272510","name":"WenxinLee","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087695368272510","authorIdStr":"4087695368272510"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/815268544","repostId":"1105876391","repostType":4,"repost":{"id":"1105876391","kind":"news","pubTimestamp":1630680345,"share":"https://ttm.financial/m/news/1105876391?lang=&edition=fundamental","pubTime":"2021-09-03 22:45","market":"other","language":"en","title":"Bitcoin may be clearing resistance at 3-month high; Ether rallies to $4K","url":"https://stock-news.laohu8.com/highlight/detail?id=1105876391","media":"seekingalpha","summary":"Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin contin","content":"<ul>\n <li>Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin continues to underperform Ether's price growth, climbing a mere ~75% in the same time frame.</li>\n <li>Ether is clearly ahead of the game, rising to 3-month highs on Wednesday, while Bitcoin (BTC-USD) rose to its highest level in three months on Friday.</li>\n <li>If the price of BTC fully breaks out of strong $50K resistance, there may be a case of 'fear of missing out', or FOMO traders coming back into the crypto market to take advantage of any upside momentum, Forex Trader Christopher Lewis notes in a blog post.</li>\n <li>Bitcoin's (BTC-USD) network hash rate has also improved from its trough in end-June, standing at 129.2 exahashes per second, which is already up 5 EH/s from the start of the week, implying more upside for BTC if the hash rate continues to climb, Cointelegraph reports.</li>\n</ul>\n<ul>\n <li>Bitcoin is testing $51K, while ETH flirts with $4K level.</li>\n <li>Bitcoin-related stocks were moving higher,BTCM shares rose nearly 10%.</li>\n</ul>\n<ul>\n <p></p>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin may be clearing resistance at 3-month high; Ether rallies to $4K</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin may be clearing resistance at 3-month high; Ether rallies to $4K\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-03 22:45 GMT+8 <a href=https://seekingalpha.com/news/3737159-bitcoin-finally-soars-to-3-month-high-ether-rallies-to-4k><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin continues to underperform Ether's price growth, climbing a mere ~75% in the same time frame.\nEther is ...</p>\n\n<a href=\"https://seekingalpha.com/news/3737159-bitcoin-finally-soars-to-3-month-high-ether-rallies-to-4k\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc.","FTFT":"富册金融科技","BTCM":"BIT Mining"},"source_url":"https://seekingalpha.com/news/3737159-bitcoin-finally-soars-to-3-month-high-ether-rallies-to-4k","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1105876391","content_text":"Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin continues to underperform Ether's price growth, climbing a mere ~75% in the same time frame.\nEther is clearly ahead of the game, rising to 3-month highs on Wednesday, while Bitcoin (BTC-USD) rose to its highest level in three months on Friday.\nIf the price of BTC fully breaks out of strong $50K resistance, there may be a case of 'fear of missing out', or FOMO traders coming back into the crypto market to take advantage of any upside momentum, Forex Trader Christopher Lewis notes in a blog post.\nBitcoin's (BTC-USD) network hash rate has also improved from its trough in end-June, standing at 129.2 exahashes per second, which is already up 5 EH/s from the start of the week, implying more upside for BTC if the hash rate continues to climb, Cointelegraph reports.\n\n\nBitcoin is testing $51K, while ETH flirts with $4K level.\nBitcoin-related stocks were moving higher,BTCM shares rose nearly 10%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812159080,"gmtCreate":1630566678940,"gmtModify":1676530342117,"author":{"id":"4087695368272510","authorId":"4087695368272510","name":"WenxinLee","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087695368272510","authorIdStr":"4087695368272510"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/812159080","repostId":"1105808841","repostType":4,"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":814554788,"gmtCreate":1630850094244,"gmtModify":1676530405697,"author":{"id":"4087695368272510","authorId":"4087695368272510","name":"WenxinLee","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087695368272510","authorIdStr":"4087695368272510"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/814554788","repostId":"1186003479","repostType":4,"isVote":1,"tweetType":1,"viewCount":241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815268544,"gmtCreate":1630681248188,"gmtModify":1676530375916,"author":{"id":"4087695368272510","authorId":"4087695368272510","name":"WenxinLee","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087695368272510","authorIdStr":"4087695368272510"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/815268544","repostId":"1105876391","repostType":4,"repost":{"id":"1105876391","kind":"news","pubTimestamp":1630680345,"share":"https://ttm.financial/m/news/1105876391?lang=&edition=fundamental","pubTime":"2021-09-03 22:45","market":"other","language":"en","title":"Bitcoin may be clearing resistance at 3-month high; Ether rallies to $4K","url":"https://stock-news.laohu8.com/highlight/detail?id=1105876391","media":"seekingalpha","summary":"Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin contin","content":"<ul>\n <li>Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin continues to underperform Ether's price growth, climbing a mere ~75% in the same time frame.</li>\n <li>Ether is clearly ahead of the game, rising to 3-month highs on Wednesday, while Bitcoin (BTC-USD) rose to its highest level in three months on Friday.</li>\n <li>If the price of BTC fully breaks out of strong $50K resistance, there may be a case of 'fear of missing out', or FOMO traders coming back into the crypto market to take advantage of any upside momentum, Forex Trader Christopher Lewis notes in a blog post.</li>\n <li>Bitcoin's (BTC-USD) network hash rate has also improved from its trough in end-June, standing at 129.2 exahashes per second, which is already up 5 EH/s from the start of the week, implying more upside for BTC if the hash rate continues to climb, Cointelegraph reports.</li>\n</ul>\n<ul>\n <li>Bitcoin is testing $51K, while ETH flirts with $4K level.</li>\n <li>Bitcoin-related stocks were moving higher,BTCM shares rose nearly 10%.</li>\n</ul>\n<ul>\n <p></p>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin may be clearing resistance at 3-month high; Ether rallies to $4K</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin may be clearing resistance at 3-month high; Ether rallies to $4K\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-03 22:45 GMT+8 <a href=https://seekingalpha.com/news/3737159-bitcoin-finally-soars-to-3-month-high-ether-rallies-to-4k><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin continues to underperform Ether's price growth, climbing a mere ~75% in the same time frame.\nEther is ...</p>\n\n<a href=\"https://seekingalpha.com/news/3737159-bitcoin-finally-soars-to-3-month-high-ether-rallies-to-4k\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"COIN":"Coinbase Global, Inc.","FTFT":"富册金融科技","BTCM":"BIT Mining"},"source_url":"https://seekingalpha.com/news/3737159-bitcoin-finally-soars-to-3-month-high-ether-rallies-to-4k","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1105876391","content_text":"Recently, Ethereum has been on a tear, surging ~130% from its trough in mid-July, but Bitcoin continues to underperform Ether's price growth, climbing a mere ~75% in the same time frame.\nEther is clearly ahead of the game, rising to 3-month highs on Wednesday, while Bitcoin (BTC-USD) rose to its highest level in three months on Friday.\nIf the price of BTC fully breaks out of strong $50K resistance, there may be a case of 'fear of missing out', or FOMO traders coming back into the crypto market to take advantage of any upside momentum, Forex Trader Christopher Lewis notes in a blog post.\nBitcoin's (BTC-USD) network hash rate has also improved from its trough in end-June, standing at 129.2 exahashes per second, which is already up 5 EH/s from the start of the week, implying more upside for BTC if the hash rate continues to climb, Cointelegraph reports.\n\n\nBitcoin is testing $51K, while ETH flirts with $4K level.\nBitcoin-related stocks were moving higher,BTCM shares rose nearly 10%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":333,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860767592,"gmtCreate":1632215849816,"gmtModify":1676530726799,"author":{"id":"4087695368272510","authorId":"4087695368272510","name":"WenxinLee","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087695368272510","authorIdStr":"4087695368272510"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860767592","repostId":"1189685868","repostType":4,"repost":{"id":"1189685868","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631714905,"share":"https://ttm.financial/m/news/1189685868?lang=&edition=fundamental","pubTime":"2021-09-15 22:08","market":"us","language":"en","title":"BioNTech SE stock jumped 4% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1189685868","media":"Tiger Newspress","summary":"BioNTech SE stock jumped 4% in morning trading as Pfizer said booster shots of vaccine restore wanin","content":"<p>BioNTech SE stock jumped 4% in morning trading as Pfizer said booster shots of vaccine restore waning Immunity.Pfizer shares rose 0.7%.</p>\n<p><img src=\"https://static.tigerbbs.com/fb4c307ca1b61c145bfb12a955ecf588\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Pfizer Inc. said that data from the U.S. and Israel suggest that the efficacy of its Covid-19 vaccine wanes over time, and that a booster dose was safe and effective at warding off the virus and new variants.</p>\n<p>The company detailed the data in a presentation it will deliver to a meeting of outside advisers to the Food and Drug Administration on Friday. The panel is expected to make recommendations for whether more Americans should receive booster shots.</p>\n<p>“Real-world data from Israel and the United States suggest that rates of breakthrough infections are rising faster in individuals who were vaccinated earlier,” Pfizer said in its presentation, which was posted on the FDA website. The drug giant is partnering with Germany’s BioNTech SE to make the shots.</p>\n<p>The decrease in effectiveness is “primarily due to waning of vaccine immune responses over time,” rather than the delta variant, Pfizer researchers said in the presentation.</p>\n<p><b>Unpublished Data</b></p>\n<p>According to a meeting agenda the FDA posted on its website, in addition to the Pfizer presentation, the Friday panel will include presentations from the Centers for Disease Control and Prevention, FDA staff and researchers from Israel and the U.K.</p>\n<p>The Israel officials will present data from that country on booster protection against infections and severe disease, according to the agenda, and a professor of medical statistics from the University of Bristol will present data on real-world vaccine effectiveness.</p>\n<p>While its vaccine continues to provide strong protection against hospitalizations and severe disease in the U.S., Pfizer said, data from Israel and elsewhere suggests that reduction in efficacy against infection may be followed by reduced effectiveness against severe disease, especially among vulnerable elderly people.</p>\n<p>Early unpublished data from an Israeli health maintenance organization suggest that a third booster dose is highly effective in areas where the delta variant is dominant, according to the Pfizer document. Giving a third dose to people more than 60 years old was associated with 86% effectiveness against testing positive for Covid starting at least a week after the booster, Pfizer said.</p>\n<p>Pfizer also detailed immune response results from a final-stage trial of booster shots in over 300 people, showing that a third dose bolstered blood antibody levels. One month after the third dose, levels of the protective antibodies were more than triple what they had been a month after the second shot.</p>\n<p>No new unexpected side effects were identified from safety data associated with boosters in the final-stage study, according to the Pfizer report. Consideration of a booster dose six months after a second dose of its shot is warranted, based on similarities between the outbreaks in Israel and the U.S., Pfizer said.</p>\n<p><b>Signs of Friction</b></p>\n<p>Marion Gruber, one of two top vaccine officials who FDA recently said will step down later this year, is also scheduled to speak. Gruber was co-author of an article in The Lancet earlier this week arguing that booster shots weren’t yet necessary for most people. The departures of the two longtime agency staff are a potential sign of friction over the Biden booster plan.</p>\n<p>The FDA hasn’t yet posted its staff report on the booster data. The agency’s documents are typically released 48 hours before the start of a panel meeting.</p>\n<p>The FDA is working as quickly as possible to post the items throughout the day as they are finalized and available, spokesperson Alison Hunt said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioNTech SE stock jumped 4% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioNTech SE stock jumped 4% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-15 22:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BioNTech SE stock jumped 4% in morning trading as Pfizer said booster shots of vaccine restore waning Immunity.Pfizer shares rose 0.7%.</p>\n<p><img src=\"https://static.tigerbbs.com/fb4c307ca1b61c145bfb12a955ecf588\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Pfizer Inc. said that data from the U.S. and Israel suggest that the efficacy of its Covid-19 vaccine wanes over time, and that a booster dose was safe and effective at warding off the virus and new variants.</p>\n<p>The company detailed the data in a presentation it will deliver to a meeting of outside advisers to the Food and Drug Administration on Friday. The panel is expected to make recommendations for whether more Americans should receive booster shots.</p>\n<p>“Real-world data from Israel and the United States suggest that rates of breakthrough infections are rising faster in individuals who were vaccinated earlier,” Pfizer said in its presentation, which was posted on the FDA website. The drug giant is partnering with Germany’s BioNTech SE to make the shots.</p>\n<p>The decrease in effectiveness is “primarily due to waning of vaccine immune responses over time,” rather than the delta variant, Pfizer researchers said in the presentation.</p>\n<p><b>Unpublished Data</b></p>\n<p>According to a meeting agenda the FDA posted on its website, in addition to the Pfizer presentation, the Friday panel will include presentations from the Centers for Disease Control and Prevention, FDA staff and researchers from Israel and the U.K.</p>\n<p>The Israel officials will present data from that country on booster protection against infections and severe disease, according to the agenda, and a professor of medical statistics from the University of Bristol will present data on real-world vaccine effectiveness.</p>\n<p>While its vaccine continues to provide strong protection against hospitalizations and severe disease in the U.S., Pfizer said, data from Israel and elsewhere suggests that reduction in efficacy against infection may be followed by reduced effectiveness against severe disease, especially among vulnerable elderly people.</p>\n<p>Early unpublished data from an Israeli health maintenance organization suggest that a third booster dose is highly effective in areas where the delta variant is dominant, according to the Pfizer document. Giving a third dose to people more than 60 years old was associated with 86% effectiveness against testing positive for Covid starting at least a week after the booster, Pfizer said.</p>\n<p>Pfizer also detailed immune response results from a final-stage trial of booster shots in over 300 people, showing that a third dose bolstered blood antibody levels. One month after the third dose, levels of the protective antibodies were more than triple what they had been a month after the second shot.</p>\n<p>No new unexpected side effects were identified from safety data associated with boosters in the final-stage study, according to the Pfizer report. Consideration of a booster dose six months after a second dose of its shot is warranted, based on similarities between the outbreaks in Israel and the U.S., Pfizer said.</p>\n<p><b>Signs of Friction</b></p>\n<p>Marion Gruber, one of two top vaccine officials who FDA recently said will step down later this year, is also scheduled to speak. Gruber was co-author of an article in The Lancet earlier this week arguing that booster shots weren’t yet necessary for most people. The departures of the two longtime agency staff are a potential sign of friction over the Biden booster plan.</p>\n<p>The FDA hasn’t yet posted its staff report on the booster data. The agency’s documents are typically released 48 hours before the start of a panel meeting.</p>\n<p>The FDA is working as quickly as possible to post the items throughout the day as they are finalized and available, spokesperson Alison Hunt said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189685868","content_text":"BioNTech SE stock jumped 4% in morning trading as Pfizer said booster shots of vaccine restore waning Immunity.Pfizer shares rose 0.7%.\n\nPfizer Inc. said that data from the U.S. and Israel suggest that the efficacy of its Covid-19 vaccine wanes over time, and that a booster dose was safe and effective at warding off the virus and new variants.\nThe company detailed the data in a presentation it will deliver to a meeting of outside advisers to the Food and Drug Administration on Friday. The panel is expected to make recommendations for whether more Americans should receive booster shots.\n“Real-world data from Israel and the United States suggest that rates of breakthrough infections are rising faster in individuals who were vaccinated earlier,” Pfizer said in its presentation, which was posted on the FDA website. The drug giant is partnering with Germany’s BioNTech SE to make the shots.\nThe decrease in effectiveness is “primarily due to waning of vaccine immune responses over time,” rather than the delta variant, Pfizer researchers said in the presentation.\nUnpublished Data\nAccording to a meeting agenda the FDA posted on its website, in addition to the Pfizer presentation, the Friday panel will include presentations from the Centers for Disease Control and Prevention, FDA staff and researchers from Israel and the U.K.\nThe Israel officials will present data from that country on booster protection against infections and severe disease, according to the agenda, and a professor of medical statistics from the University of Bristol will present data on real-world vaccine effectiveness.\nWhile its vaccine continues to provide strong protection against hospitalizations and severe disease in the U.S., Pfizer said, data from Israel and elsewhere suggests that reduction in efficacy against infection may be followed by reduced effectiveness against severe disease, especially among vulnerable elderly people.\nEarly unpublished data from an Israeli health maintenance organization suggest that a third booster dose is highly effective in areas where the delta variant is dominant, according to the Pfizer document. Giving a third dose to people more than 60 years old was associated with 86% effectiveness against testing positive for Covid starting at least a week after the booster, Pfizer said.\nPfizer also detailed immune response results from a final-stage trial of booster shots in over 300 people, showing that a third dose bolstered blood antibody levels. One month after the third dose, levels of the protective antibodies were more than triple what they had been a month after the second shot.\nNo new unexpected side effects were identified from safety data associated with boosters in the final-stage study, according to the Pfizer report. Consideration of a booster dose six months after a second dose of its shot is warranted, based on similarities between the outbreaks in Israel and the U.S., Pfizer said.\nSigns of Friction\nMarion Gruber, one of two top vaccine officials who FDA recently said will step down later this year, is also scheduled to speak. Gruber was co-author of an article in The Lancet earlier this week arguing that booster shots weren’t yet necessary for most people. The departures of the two longtime agency staff are a potential sign of friction over the Biden booster plan.\nThe FDA hasn’t yet posted its staff report on the booster data. The agency’s documents are typically released 48 hours before the start of a panel meeting.\nThe FDA is working as quickly as possible to post the items throughout the day as they are finalized and available, spokesperson Alison Hunt said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":244,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":880071750,"gmtCreate":1631004175570,"gmtModify":1676530439850,"author":{"id":"4087695368272510","authorId":"4087695368272510","name":"WenxinLee","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087695368272510","authorIdStr":"4087695368272510"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/880071750","repostId":"1118393732","repostType":4,"isVote":1,"tweetType":1,"viewCount":241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":812159080,"gmtCreate":1630566678940,"gmtModify":1676530342117,"author":{"id":"4087695368272510","authorId":"4087695368272510","name":"WenxinLee","avatar":"https://static.tigerbbs.com/bad37890ba35bb7193190c5c08ea56fb","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4087695368272510","authorIdStr":"4087695368272510"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/812159080","repostId":"1105808841","repostType":4,"repost":{"id":"1105808841","kind":"news","pubTimestamp":1630547089,"share":"https://ttm.financial/m/news/1105808841?lang=&edition=fundamental","pubTime":"2021-09-02 09:44","market":"hk","language":"en","title":"Hong Kong: Shares extend gains at open","url":"https://stock-news.laohu8.com/highlight/detail?id=1105808841","media":"AFP","summary":"[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their ","content":"<p>[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their time ahead of the release of key US jobs data at the end of the week.</p>\n<p>The Hang Seng Index rose 0.67 per cent or 175.23 points to 26,203.52.</p>\n<p>The Shanghai Composite dipped 0.20 per cent or 7.20 points to 3,559.90, while the Shenzhen Composite Index on China's second exchange fell 0.22 per cent or 5.32 points to 2,412.57.</p>","source":"lsy1605843958005","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong: Shares extend gains at open</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong: Shares extend gains at open\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-02 09:44 GMT+8 <a href=https://www.businesstimes.com.sg/stocks/hong-kong-shares-extend-gains-at-open-3><strong>AFP</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their time ahead of the release of key US jobs data at the end of the week.\nThe Hang Seng Index rose 0.67 ...</p>\n\n<a href=\"https://www.businesstimes.com.sg/stocks/hong-kong-shares-extend-gains-at-open-3\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HSI":"恒生指数"},"source_url":"https://www.businesstimes.com.sg/stocks/hong-kong-shares-extend-gains-at-open-3","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105808841","content_text":"[HONG KONG] Hong Kong stocks began with another advance on Thursday morning as investors bide their time ahead of the release of key US jobs data at the end of the week.\nThe Hang Seng Index rose 0.67 per cent or 175.23 points to 26,203.52.\nThe Shanghai Composite dipped 0.20 per cent or 7.20 points to 3,559.90, while the Shenzhen Composite Index on China's second exchange fell 0.22 per cent or 5.32 points to 2,412.57.","news_type":1},"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}
